Companies / OnKure Therapeutics, Inc. / Activity
Activity — OnKure Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2024 as of | Barclays PLC 13F manager | New | Common stock | $75.2K | +9K | 8,741 0.02% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $116.6K | +26K | 25,564 0.06% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common stock | $126.3K | +30K | 30,499 0.08% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $150.9K | +36K | 36,444 0.09% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common stock | $2.11M | +464K | 463,662 1.14% of shares | low |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common stock | $4.99M | +1.2M | 1,204,819 2.98% of shares | low |
| Q1 2026 as of | Bvf INC/IL 13F manager | New | Common stock | $8.19M | +2.0M | 1,978,972 4.89% of shares | medium |
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common stock | $16.55M | +4.0M | 3,998,333 9.87% of shares | medium |